---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-094789"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:54:41.517008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences effects 1-for-3 reverse stock split; PRIME Phase 1b enrollment expected to complete July 2025

## Summary
- 1-for-3 reverse stock split effective July 7, 2025; post-split shares ~1,534,599.
- Split intended to regain Nasdaq minimum bid price compliance; CUSIP changed to 76135L705.
- PRIME Phase 1b study of Gemini in CKD patients: enrollment expected to complete July 2025; topline data anticipated shortly after.

## SEC filing metadata
- accession: 0000950170-25-094789
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/0000950170-25-094789-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/revb-20250707.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-094789
- JSON: https://secwatch.observer/filing/0000950170-25-094789.json
- Plain text: https://secwatch.observer/filing/0000950170-25-094789.txt

## Key facts
- Governance Changes
  REVELATION BIOSCIENCES, INC.: Filed Certificate of Amendment to effect a 1-for-3 reverse stock split (effective 2025-07-07).
  - Change: charter amendment
  - Effective: 2025-07-07
  source text: the Company filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effective on July 7, 2025, which effected a 1-for-3 reverse stock split as of 12:01 a.m. Eastern Standard Time on July 7, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017025094789/0000950170-25-094789-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.